Tolerance to the miotic effect of sarin vapor in rats after multiple low-level exposures

Journal of Ocular Pharmacology and Therapeutics

Volumn 21, Issue 3, 2005, Pages 182-195

  Dabisch, Paul A ^a,b   Burnett, David C ^b   Miller, Dennis B ^c   Jakubowski, Edward M ^b   Muse, William T ^b   Forster, Jeffry S ^b   Scotto, Jacqueline A ^b   Jarvis, Jill R ^c   Davis, Emily A ^b   Hulet, Stanley W ^b   Reutter, Sharon A ^b   Mioduszewski, Robert J ^b   Thomson, Sandra A ^b  

^a NATIONAL RESEARCH COUNCIL   (United States)

^b EDGEWOOD CHEMICAL BIOLOGICAL CENTER   (United States)

^c SCIENCE APPLICATIONS INTERNATIONAL CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; SARIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; CONTROLLED STUDY; ENZYME ACTIVITY; EXPOSURE; INTOXICATION; IRIS; MALE; MIOSIS; NONHUMAN; PUPIL; PUPIL REFLEX; RAT; VAPOR;

ACETYLCHOLINESTERASE; ADMINISTRATION, INHALATION; ANIMALS; BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; EYE; MALE; MIOSIS; RATS; RATS, SPRAGUE-DAWLEY; SARIN; VOLATILIZATION;

EID: 20544473949     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2005.21.182     Document Type: Article

References (33)

1. Palmer, T. Structure and function of enzymes. Understanding Enzymes. New York: John Wiley and Sons, 17-27, 1985.
2. Taylor, P. Anticholinesterase Agents. The Pharmacological Basis of Therapeutics. Limbird, L.E., and Hardman, J.G., editors. New York: McGraw-Hill, 161-176, 1996.
3. Mioduszewski, R.J., Manthei, J.H., Way, R.A., Burnett, D.C., Gaviola, B.P., Muse, W.T., Crouse, C.L., Anthony, J.S., Durst, H.D., Sommerville, D.R., Crosier, R.B., and Thomson, S.A. ECBC low level operational toxicology program: phase I - inhalation toxicity of sarin vapor in rats as a function of exposure concentration and duration. Tech. Rep. ECBC-TR-183, August 2001.
4. Mioduszewski, R.J., Manthei, J.H., Way, R.A., Burnett, D.C., Gaviola, B.P., Muse, W.T., Thomson, S.A., Sommerville, D.R., Crosier, R.B., Scotto, J.A., McCaskey, D.A., Grouse, C.L., and Matson, K.L. ECBC low level operational toxicology program: phase I-inhalation toxicity of sarin vapor in rats as a function of exposure concentration and duration. Tech. Rep. ECBC-TR-235, May 2002.
5. Mioduszewski, R., Manthei, J., Way, R., Burnett, D., Gaviola, B., Muse, W., Thomson, S., Sommerville, D., and Crosier, R. Interaction of exposure concentration and duration in determining acute toxic effects of sarin vapor in rats. Toxicol. Sci. 66:176-184, 2002.
6. Fredricksson, T., Hansson, C.H., and Holmstedt, B. Effects of sarin in the anesthetized and unanesthetized dog following inhalation, percutaneous absorption, and intravenous infusion. Arch. Int. Pharmacodyn. 3:288-302, 1960.
7. Bito, L.Z., and Banks, N. Effects of chronic cholinesterase inhibitor treatment: the pharmacological and physiological behavior of the anti-ChE-treated monkey (Macaca mulatto) iris. Arch. Ophthal. 32:681-686, 1969.
8. Soli, N.E., Lund Karlsen, R., Opsahl, M., and Fonnum, F. Correlations between acetylcholinesterase activity in guinea-pig iris and papillary function: a biochemical and pupillographic study. J. Neurochem. 35:723-728, 1980.
9. Lutz, P., Tomas, T., Gralewicz, S., and Nowakowska, E. Long-term effects of acute exposure to chlorphennivphos on behavioural responsiveness to amphetamine and scopolamine in rats. Int. J. Occup. Med. Environ. Health 13:215-222, 2000.
10. Sirkka, U., Nieminen, S.A., and Ylitano, P. Neurobehavioral toxicity with low doses of sarin and soman. Methods. Find. Exp. Clin. Pharmacol. 12:245-250, 1990.
11. Baille, V., Dorandeu, F., Carpentier, P., Bizot, J.C., Filliat, P., Four, E., Denis, J., and Lallement, G. Acute exposure to a low or mild dose of soman: biochemical, behavioral, and histopathological effects. Pharmacol. Biochem. Behav. 69:561-569, 2001.
12. Kawabuchi, M., Cintra, W.M., Deshpande, S.S., and Albuquerque, E.X. Morphological and electrophysiological study of distal motor nerve fiber degeneration and sprouting after irreversible cholinesterase inhibition. Synapse 8:218-228, 1991.
13. Abdel-Rahman, A., Shetty, A.K., and Abou-Donia, M.B. Acute exposure to sarin increases blood brain barrier permeability and induces neuropathological changes in the rat brain: dose-response relationships. Neuroscience 113:721-741, 2002.
14. Damodaran, T.V., Jones, K.H., Patel, A.G., and Abou-Donia, M.B. Sarin (nerve agent GB)-induced differential expression of mRNA coding for the acetylcholinesterase gene in the rat central nervous system. Biochem. Pharmacol. 65:2041-2047, 2003.
15. Van Helden, H.P., Trap, H.C., Oostdijk, J.P., Kuijpers, W.C., Langenberg, J.P. and, Benschop, H.P. Long-term, low-level exposure of guinea pigs and marmosets to sarin vapor in air: lowest observable effect level. Toxicol. Appl. Pharmacol. 189:170-179, 2003.
16. Grob, D., and Harvey, J.C. Effects in man of the anti-cholinesterase compound sarin (isopropyl methyl phosphonofluoridate). J. Clin. Invest. 37:350-368, 1958.
17. Dube, S.N., Kumar, P., Kumar, D., and Das Gupta, S. Route-specific cardiorespiratory and neuromuscular changes following organophosphorus poisoning in rats. Arch. Int. Pharmacodyn. Ther. 321:112-122, 1993.
18. Eaton, D.L., and Klaassen, C.D. Principles of toxicology. Casarett and Doull's Toxicology. Klaassen, CD, editor. New York: McGraw-Hill, 13-15.
19. The Use of Animals in Department of Defense Programs. Army Regulation 70-18. United States Army Publishing Directorate.
20. Institute of Laboratory Animal Resources, Commission of Life Sciences, Research Council. Guide for the Care and Use of Laboratory Animals. Washington, DC National Academy Press, 1996.
21. Muse, W., Anthony, S., Buettner, L., Grouse, C., Grouse, L., Mioduszewski, R., and Thomson, S. Generation, sampling, and analysis of sarin (GB) vapor for inhalation studies. Proceedings of the International Chemical Weapons Demilitarization Conference (CWD 2000) 21-24 May, 2000, The Hague, Netherlands.
22. th Annual Northeast Bioengineering Conference, Newark, NJ, 22-23 March 2003.
23. Jakubowski, E.M., McGuire, J.M., Evans, R.A., Edwards, J.L., Hulet, S.W., Benton, B.J., Forster, J.S., Burnett, D.C., Muse, W.T., Matson, K., Crouse, C.L., Mioduszewski, R.J., and Thomson, S.A. Quantification of fluoride ion released sarin in red blood cell samples by gas chromatography-chemical ionization mass spectrometry using isotope dilution and large volume injection. J. Anal. Toxicol. 28:357-363, 2004.
24. Sim, V.M. Effect on pupil size of exposure to GB vapour. Directorate of Chemical Defence Research and Development [Portion of Technical Paper #531], 1956.
25. Harris, L.S., Shimmyo, M., and Mittag, T.W. Effects of echothiophate on cholinesterases in cat irides. Arch. Ophthalmol. 91:57-59, 1974.
26. Darvesh, S., Hopkins, D.A., and Geula, C. Neurobiology of butyrylcholinesterase. Nat. Rev. Neurosci. 4:131-138, 2003.
27. Sevelova, L., Bajgar, J., Saxena, A., and Doctor, B.P. Protective effect of equine butyrylcholinesterase in inhalation intoxication of rats with sarin: determination of blood and brain cholinesterase activities. Inhal. Toxicol. 16:531-536, 2004.
28. Moroi, S.E., and Lichter, P.R. Ocular pharmacology. In: The Pharmacological Basis of Therapeutics. Limbird, L.E. and Hardman, J.G., editors. McGraw-Hill, New York, p. 1619-1645, 1996.
29. Cioffi, C.L., and el-Fakahany, E.E. Lack of alterations in muscarinic receptor subtypes and phosphoinositide hydrolysis upon acute DFP treatment. Eur. J. Pharm. 156:35-34, 1988.
30. Tandon, P., Padilla, S., Barone, S., Jr., Pope, C.N., and Tilson, H.A. Fenthion produces a persistent decrease in muscarinic receptor function in the adult rat retina. Toxicol. Appl. Pharmacol. 125:271-280, 1994.
31. Brown, M.A., and Brix, K.A. Review of health consequences from high-, intermediate- and low-level exposure to organophosphorus nerve agents. J. Appl. Toxicol. 18:393-408, 1998.
32. Okudera, H. Clinical features of nerve gas terrorism in Matsumoto. J. Clin. Neurosci. 9:17-21, 2002.
33. Imai, H., Miyata, M., Uga, S., and Ishikawa, S. Retinal degeneration in rats exposed to an organophoshphate pesticide. Environ. Res. 30:453-465, 1983.